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ABSTRACT
DNA built from modular repeats presents a challenge
for gene synthesis. We present a solid surface-based
sequential ligation approach, which we refer to as it-
erative capped assembly (ICA), that adds DNA repeat
monomers individually to a growing chain while using
hairpin ‘capping’ oligonucleotides to block incom-
pletely extended chains, greatly increasing the
frequency of full-length final products. Applying ICA
toamodelproblem,constructionofcustomtranscrip-
tion activator-like effector nucleases (TALENs) for
genome engineering, we demonstrate efficient
synthesis of TALE DNA-binding domains up to 21
monomers long and their ligation into a nuclease-
carrying backbone vector all within 3h. We used ICA
to synthesize 20 TALENs of varying DNA target site
length and tested their ability to stimulate gene
editing by a donor oligonucleotide in human cells.
All the TALENS show activity, with the ones >15
monomers long tending to work best. Since ICA
builds full-length constructs from individual
monomers rather than large exhaustive libraries of
pre-fabricated oligomers, it will be trivial to incorpor-
ate future modified TALE monomers with improved or
expanded function or to synthesize other types of
repeat-modular DNA where the diversity of possible
monomers makes exhaustive oligomer libraries
impractical.
INTRODUCTION
Custom gene synthesis continues to grow in its importance
for molecular and synthetic biology (1). Currently, DNA
constructs longer than  200bp are usually produced by
assembly polymerase chain reaction (PCR) or ligation
(1–3) of multiple oligonucleotides that are themselves
synthesized by sequential chemical coupling of nucleotides
onaglasscolumn(4)ormicroarray(5).Recentlydeveloped
assembly-from-microarray approaches (6,7) in particular
promise drastic reductions in time and costs of gene
synthesis. However, DNA constructs built from repetitive
modules have not been amenable to these methods because
of the high likelihood of oligonucleotides incorporating
into erroneous parts of constructs (8,9). Therefore, new
methods of assembling repeat-module DNA would be
highly desirable, especially ones that are automatable or
highly scalable. We designed a method, which we refer to
as iterative capped assembly (ICA; Figure 1), that involves
rapid assembly of repeat-module DNA by sequential
ligation of monomers on a solid support together with
capping oligonucleotides to increase the frequency of
full-length products. The capping oligonucleotides act by
ligating to and inactivating incomplete chains generated
during the process by imperfect monomer ligation efﬁ-
ciency. We reasoned that one ideal application for ICA
would be rapid parallelized construction of transcription
activator-like (TAL) effector proteins (10) for genome
engineering. These proteins originally from Xanthomonas
bacteria(11)carryaDNA-bindingdomain(referredtohere
astheTALE)consistingofarepeatingchainofnearlyiden-
tical 34-amino acid monomers. Each monomer addresses a
single DNA target base when the TALE anneals to the
major groove of DNA (12,13), with four common
monomer variants (differing only at the repeat-variable
diresidue(RVD)atpositions12and13(10))eachoptimally
binding one of the four DNA base pairs. TALEs are there-
fore of great interest to genome engineering since their
RVD monomers can be programmably rearranged to
form custom DNA-binding domains that, when fused to
other user-speciﬁed domains, may allow targeting of a
vast range of proteins and other molecules to particular
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application is the design of pairs of TALEs each fused to
monomers of the obligate dimer-acting FokI nuclease,
which together create a target locus-speciﬁc endonuclease
(TALE-nuclease or TAL effector nucleases (TALEN)
(14)). When two TALENs bind to closely spaced target
DNA sites, FokI will dimerize and create a local double-
strand DNA break, allowing targeted gene knockout if the
cell repairs the break by non-homologous end-joining
(NHEJ;(15,16))orincorporationofdonorDNAsequences
(17) by homologous recombination or other repair
mechanisms. Here, we apply ICA to custom TALEN
production and demonstrate efﬁcient assembly of TALEs
up to 21 monomers long followed by ligation into a
nuclease backbone vector all within 3h. We show that the
capping oligonucleotides are essential for generation of
pure full-length products. To investigate the activity of
TALENs synthesized by our method, we produced 20
TALEN variants with a range of lengths and measured
the ability of 19 of them to stimulate gene editing by a
single-stranded donor oligonucleotide of a reporter gene
in human cells. All of the TALENs we tested facilitated
donor incorporation, providing to our knowledge the ﬁrst
demonstration of TALEN-mediated gene editing by an
oligonucleotide. Although several methods for TALE
assembly have been reported (15,18–20), ICA is, to our
knowledge, unique in its ability to build TALEs in an
automatable fashion from individual monomers; this
property should allow facile introduction of future
improved TALE monomers and application of ICA to
other modular constructs built from larger monomer
repertoires than that of TALEs. ICA may also allow
ultra-high-throughput synthesis of repeat-module DNA
using microarray printing technology.
MATERIALS AND METHODS
Sequences of all oligonucleotides used in this study are in
Supplementary Table S1; double-stranded oligonucleotide
pairing schemes are in Supplementary Table S2. All
TALEN designs are in Supplementary Table S3. Maps
of the TALEN backbone and defective EGFP reporter
lentiviral plasmids are in Supplementary Files 2.
Monomer construction
TALE monomers were prepared by PCR and puriﬁcation
followed by BsmBI digestion and puriﬁcation. Each 100ml
PCR contained 50ml2   Phusion HF master mix (NEB),
400nM each primer and 4ng template RVD plasmid,
taken from (18). PCR was performed with 98 C for
2min followed by 25 cycles at 98 C for 20s; 60 C for
30s and 72 C for 20s. Products were puriﬁed on
QIAquick columns (Qiagen) with two buffer PE washes
and eluted in 50ml elution buffer (EB). Typically, three
100ml PCRs were pooled onto each QIAquick column.
Forty-ﬁve microliters of each puriﬁed product was
included in a 100-ml reaction containing 1  NEBuffer 4,
0.1mg/ml bovine serum albumin (BSA) and 3ml BsmBI.
Reactions were incubated at 55 C for 3h and then puriﬁed
with QIAquick columns, eluting in 50ml EB.
ICA ligation procedure
Before the ligation steps, all double-stranded oligonucleo-
tides were prepared by mixing equal volumes of the two
relevant single-stranded oligonucleotides at 100mM each,
heating at 95 C and then ramping down to 25 C at 0.1 C/s.
Capping oligonucleotides were diluted to 5mM and then
subjected to the same heat conditions as above. For each
Figure 1. ICA of repeat-module DNA. ICA assembles repeat monomers into chains in a cycling A-B-C ligation-wash pattern with capping oligo-
nucleotides to block incompletely extended chains. In each A step, monomer A is ligated to monomer C (except the ﬁrst ABC cycle (shown) where A
is ligated to a biotinylated initiator oligonucleotide immobilized on streptavidin beads). A hairpin capping oligonucleotide (black) is included to cap
unligated monomer B (not relevant in the ﬁrst cycle). In B steps, monomer B is ligated to monomer A and a capping oligo is included to cap
unligated monomer C from the previous step (or unligated initiator in the ﬁrst cycle). In C steps, monomer C is ligated to monomer B and a capping
oligo is included to cap unligated monomer A from the previous step. This ABC cycling pattern continues until a ﬁnal ligation with a terminator
oligonucleotide (T, Final). A single exception occurs in the sixth step where a modiﬁed C monomer, Cseq, is used that allows later annealing of a
sequencing primer. After the ﬁnal ligation, products are eluted from the beads and brieﬂy ampliﬁed by PCR before Golden-Gate assembly into a
backbone vector, e.g. assembly of TALEs into a FokI nuclease-carrying plasmid, using BsaI. (a) Post-elution PCR products for TALES of length 11,
15, 18 and 19 monomers, plus the same 19-mer synthesized without capping oligos (nb). (b) AfeI digestions of TALE-nuclease (TALEN) plasmids
from six randomly picked colonies per construct. Expected sizes of full-length TALE insert bands are labeled with red arrows, and the full-length
clone frequencies are shown.
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M-270 beads (Life Technologies) were washed twice in
2  Binding and Wash (BW) buffer (2M NaCl, 10mM
Tris–HCl pH 8.0, 1mM ethylenediaminetetraacetic acid
pH 8.0, 0.2% w/w Tween-20), resuspended in 5ml2   BW
buffer, mixed with 5ml of 10nM initiator oligonucleotide
and rotated at room temperature for 30min. Beads were
washedtwicein0.5 BWbufferandresuspendedina10-ml
reaction mix representing the ﬁrst ligation step. Each
ligation reaction contained 5ml2   rapid ligation buffer
and 0.5ml T7 ligase (Enzymatics), 1ml5mM capping oligo
and 50ng of the relevant TALE monomer. The beads were
rotated for 2min at room temperature before being washed
twice in 0.5  BW buffer and resuspended in the next
ligation reaction. Ligations and washes were repeated for
the requisite number of steps (up to 20 total ligations)
before a ﬁnal ligation containing the appropriate
terminator oligonucleotide instead of a TALE monomer.
After the terminator ligation, beads were washed once in
water and either resuspended in 15ml water with 0.01%
Tween-20 and heated to 95 C for 3min to elute the DNA
or resuspended directly in Golden-Gate reaction mix for
assembly into the nuclease backbone.
TALE elution and ampliﬁcation
Eluted TALE ligation products were ampliﬁed in 50-ml
PCRs containing 25ml Phusion 2  HF master mix,
400nM each post-elution primer Fwd and Rvs and
SYBR green I (Invitrogen) at 0.4  concentration. PCR
was performed on a BioRad Opticon Monitor real-time
PCR machine with 98 C for 2min followed by cycles of:
98 C, 20s; 60 C, 30s and 72 C, 45s. PCRs were stopped as
soon as a SYBR-green ampliﬁcation signal could be
detected, usually after 10–15 cycles. PCR products were
visualized by gel electrophoresis and puriﬁed by
polyethylene glycol precipitation on carboxylated
magnetic beads, using a cheaper self-made version (21) of
Agencourt Ampure beads.
Assembly of TALEs into the nuclease backbone
Ligated TALE domains were assembled into a
nuclease-carrying backbone vector using the Golden-Gate
method (22) as applied by (18). 3–5ng of puriﬁed
post-elution PCR product (or half of the washed beads
using the direct assembly method (see Results)) was
added to a 10-ml reaction containing 1  NEBuffer 4,
1mM ATP, 0.1mg/ml BSA, 0.5ml T7 ligase (Enzymatics),
0.5ml BsaI (NEB) and 100ng TALEN backbone plasmid.
This plasmid is based on the nuclease plasmid of (18) but
modiﬁed using PCR and isothermal assembly (23) to
remove the C-terminal 0.5 TALE repeat. The
Golden-Gate reaction was ﬁrst subjected to 10 cycles at
37 C, 2min and 20 C, 3min; then 10min at 50 C and
10min at 80 C. 1.5ml of each product was transformed
into half a vial of TOP10 cells (Life Technologies) and
plated onto Luria–Bertani (LB) agar ampicillin.
TALEN veriﬁcation
After overnight incubation of the TALEN transformation
plates, colonies were picked and swirled ﬁrst in 100mlL B
containing 100mg/ml ampicillin and then in 100ml water.
Ten microliters of this water was then included in a 50ml
PCR containing 1  Phusion HF master mix, 250nM each
dNTP, 0.4  SYBR green I and 400nM each primer
(TALE-seq-F1 and TALE-seq-F2 for short colony PCR,
Whole-TALEN-PCR-Fwd and Whole-TALEN-PCR-Rvs
for long colony PCR (See Results)). PCRs were performed
at 98 C for 3min followed by 30 cycles of: 98 C, 20s;
60 C, 30s and 72 C, 45s (2min for long colony PCR).
Products were visualized by gel electrophoresis. Saved
colonies in LB corresponding to full-length products
were grown overnight in 5ml LB-amp, and the TALEN
plasmids were puriﬁed by Qiagen Miniprep. Plasmids
or puriﬁed long colony PCR products were Sanger-
sequenced in three reads using the sequencing primers
TALE-seq-F1, TALE-seq-F2 and TALE-seq-R1.
Sequences were analyzed with custom scripts to check
for perfect TALEN coding sequence.
TALEN activity reporter cell construction
To generate a reporter systemfor assayingTALEN activity,
we constructed a lentiviral vector carrying an EGFP gene
driven by the EF1a promoter that is defective due to a
non-functional ACG start codon (Figure 2a). EGFP is
linked by an internal ribosome entry site to a functional
mCherry sequence, to allow ﬂuorescent selection of cells
carrying genomically integrated reporter after transduction.
The construct also contains an eight-nucleotide degenerate
A/C/T (H) barcode at the 50-untranslated region to allow
later identiﬁcation of each unique genomic insertion into
the reporter cell line. The lentiviral vector was created by
standard PCR and cloning techniques including isothermal
assembly (23). In the ﬁnal cloning step, a PCR product
carrying degenerate bases at the barcode was assembled
into the backbone, transformed into Stbl3 cells (Life
Technologies) and 90% of the transformation mixture was
grown up directly in LB ampicillin and puriﬁed by QIAgen
Maxiprep. The remaining 10% was plated out and  300
colonies were generated, with 10/10 colony PCRs showing
thecorrectinsertsize.Fromtheseresultsweinferredthatthe
puriﬁed library had a diversity of several thousand, making
any handful of lentiviral integration events extremely likely
to carry unique barcode sequences. The lentiviral plasmid
was transfected by Lipofectamine 2000 with psPAX2
(Addgene plasmid 12260) and pMD2.G (Addgene plasmid
12259) packaging plasmids (contributed by the Didier
Trono Lab) into cultured Lenti-X 293T cells (Clontech) to
produce lentivirus. Supernatant was collected 48 and 72h
post-transfection, sterile ﬁltered, concentrated with the
Lenti-X Concentrator (Clontech) and added to fresh 293T
cells with polybrene. Fluorescence-activated cell sorting
(FACS) was used to isolate single mCherry-positive cells
after 1 week. A single clonal line was then chosen for
TALEN transfection experiments.
TALEN transfections
The day before all transfections, reporter cells were
trypsinized, centrifuged, resuspended in DMEM +
GlutaMax-1 medium with 10% fetal bovine serum and
transferred to 24-well poly-L-lysine-coated plates with
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incubation at 37 Ci n5 %C O 2, TALENs and the donor
oligonucleotide EGFP-rescue-75 were transfected into the
cells using Lipofectamine 2000 (Life Technologies). DNA
mixes containing 300ng of each plasmid and 200ng of
the donor were made up in 50ml Opti-MEM reduced
serum medium (Life Technologies). 2.5ml Lipofectamine
2000 was mixed with 50ml Opti-MEM and left to stand
for 5min. The DNA mix and lipofectamine mix were then
combined and incubated at room temperature for 30min
before the whole 100–130ml transfection mix was added
to the cells. After 24h of incubation, the wells were
replaced with fresh medium containing penicillin/strepto-
mycin antibiotic. After a further 3 days of incubation,
cells were imaged, dissociated by TrypLE Express (Life
Technologies), neutralized in media and then quantiﬁed
by ﬂow cytometry on a BD Aria Fortessa platform or
sorted by FACS.
Sequencing the reporter cell target region
To count the number of reporter construct genomic inte-
grations in the initial reporter cell line, and to sequence the
TALEN target region after transfections, a few thousand
cells were scraped off the relevant culture dish with a
pipette and 8.9ml of the cells in medium were added to
0.1ml prepGEM tissue protease enzyme and 1ml1 0  
prepGEM gold buffer (ZyGEM). Reactions were
incubated for 5min at 75 C and then 5min at 95 C. The
reactions were then added to 40ml of PCR mix containing
35.5mlp l a t i n u m1 . 1   Supermix (Invitrogen), 250nM each
dNTP and 400nM primers BarcodeF and BarcodeR.
Reactions were subjected at 95 C for 3min followed by
40 cycles of 95 C, 20s; 60 C, 30s and 72 C, 20s.
Products were visualized by gel electrophoresis, cloned by
the TOPO-TA method (Life Technologies) and sequenced
with the M13R primer. Each of 96 random sequences
showed one of only two barcodes, indicating that this
line carries two genomic copies of the reporter gene.
RESULTS
ICA: rapid, individual monomer-based DNA assembly
For rapid, solid surface-based synthesis of repetitive DNA
such as TALEs, we desired an efﬁcient, scalable method of
ligating individual DNA monomers into chains at least 20
monomers long. An ideal such method would overcome
incomplete ligation efﬁciency and avoid monomers
self-ligating in individual steps without requiring
(a)
(d)
(e)
(b)
(c)
Figure 2. Testing activity of TALEN variants on a human cell reporter system. (a) To generate a TALEN activity reporter system we integrated a
barcoded (H8, H=A/C/T) defective EGFP gene carrying a non-functional ACG start codon into the genome of 293T cells. Gene editing by a 75-nt
donor oligonucleotide stimulated by a TALEN-mediated double-strand break near the target site should correct the start codon and rescue EGFP
expression. We designed 21 length variants of TALENs designed to ﬂank the defective site. TALEN RVD sequences are shown. White monomer
circles represent ‘0th’ positions of the DNA target sequence bound by the TALE N-terminus. (b) Post-elution PCR products of the ligated right
TALE domains (for R11 see TAL-11, Figure 1b) and AfeI digestions of corresponding assembled and sequence-veriﬁed TALEN plasmids.
(c) Epiﬂuorescent microscopy and ﬂow cytometry results after transfection of the reporter cells with the L19/R19 TALEN pair and the donor
oligonucleotide. (d) Gene editing events (green sequences, functional start codon underlined) were conﬁrmed by sequencing of the target site in
EGFP+cells, with widespread NHEJ (black sequences) also observed (red=unmodiﬁed sequence). Reporter barcodes (blue) identify from which of
two genomic reporter copies each sequence is derived. (e) EGFP rescue activity of all successfully synthesized TALEN length variants. Each TALEN
was transfected together with the donor and either L19 or R19, whichever was relevant. Bar colors indicate the DNA base located at the ‘0th’
position for each TALEN tested. Error bars show standard error (n=3 for all).
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monomer carrying different ligation overhangs. We, there-
fore, designed a method, ICA (Figure 1), that involves suc-
cessive monomer ligations on a solid support and capping
oligonucleotides to inactivate incomplete chains. The
method consists of iterative cycles of three ligation steps,
each adding one of only three versions (A–C) of the basic
monomer, with monomer ‘type’ (such as the required RVD
inTALE domainsynthesis)selectableineachstep. For each
monomer type, its A–C versions are identical except they
carry distinct four-nucleotide overhangs created by BsmBI
digestion of their monomer precursors (PCR products). As
in (24) the overhangs differ only in redundant codon
positions so ultimately produce identical amino acid
sequence. The ‘right’ overhang of the A monomer will
ligate only to the ‘left’ overhang of the B monomer. The B
monomer right overhang will only ligate to the C monomer
left overhang, and the C right overhang only to the A left
overhang. Hence, by sequentially introducing monomers
and ligase to an immobilized chain in a repeating A, B, C,
A,B,C,etc.cyclingpattern,withfreechoiceofthemonomer
type used in each step, a chain of arbitrary length and
monomer sequence can be built. The chain is anchored
with a biotinylated initiator oligo coupled to streptavidin-
coatedmagneticbeads.Theinitiatorcarriesarightoverhang
identical to that of the C monomer and will therefore ligate
to the left overhang of the A monomer during the ﬁrst step.
Importantly, the A-B-C pattern of sequential addition
allows the use of short hairpin oligonucleotides (capping
oligos) to inactivate incomplete chains. For example, after
the ﬁrst ligation step not all initiators will be coupled to A
monomers because of imperfect ligation efﬁciency. By sim-
ultaneously introducing in the second step the B monomer
and a capping oligo that will ligate to the right overhang of
the initiator (in later cycles to the C monomer), residual
unligated initiators will be blocked by the capping oligo
while the successfully coupled chains from the ﬁrst step
can ligate to the B monomer to form an ‘initiator-A-B’
chain. Similarly, in the third step the C monomer, which
will ligate to form ‘initiator-A-B-C’ chains, can be
co-introduced with a capping oligo that will ligate to the A
monomer and thus block ‘initiator-A’ chains left by incom-
plete ligation in the second step. This pattern is repeated in
every step, where a monomer to extend full-length chains is
co-introduced with a capping oligo to block chains unsuc-
cessfullyextendedinthepreviousstep.ForTALEsynthesis,
asingleexceptiontotheA-B-Cruleoccursinstep6,wherea
modiﬁed version of the C monomer, Cseq, is used that
carries multiple synonymous substitutions allowing later
annealing of a speciﬁc sequencing primer (18). Once a
capping oligo ligates to a chain, further ligations onto that
chainarepreventedandsincethehairpincovalentlylinksthe
two strands of the DNA duplex, rapid self-annealing will
reduce the chance of the chain interfering with downstream
PCR.Intheﬁnalligationstep,adouble-strandedterminator
oligonucleotide is added to the chain. Both the terminator
and initiator oligos carry primer sites that allow PCR amp-
liﬁcationofthefull-lengthassembliesafterheatelutionfrom
the beads,as well asrestriction sites that allow Golden-Gate
cloning into a backbone vector. The terminator used here
carries the coding sequence for the ‘0.5 repeat’ encoding the
ﬁnal base of the DNA recognition site that is a feature of
TALE proteins (10,25). In ICA, there are three possible
versions (A–C) of the ﬁnal full monomer depending on the
chain length, and for TALE synthesis, four possible RVD
types, requiring 12 different terminator oligos to allow ter-
mination of TALEs of any length and ﬁnal DNA target
base. Since all DNA target site speciﬁcity is encoded in the
ﬁnal ligated TALE chain, only a single backbone vector is
needed for all TALENs.
Efﬁcient synthesis of different length TALE domains
To test the ICA method, we performed serial ligations of
monomers to construct TALEs of lengths 11, 15, 18 and
19 (not including the ‘0th’ position bound by the TALE
N-terminus). We ﬁrst prepared the TALE monomers by
PCRfromplasmidmonomertemplates,usingfour different
primer pairs to produce the A, B, C and Cseq versions for
eachTALEmonomer.PCRproductswerepuriﬁed,digested
with BsmBI to generate ligatable overhangs and puriﬁed
again.Aftercouplingabiotinylatedinitiatoroligonucleotide
to streptavidin-coated magnetic beads, each ligation cycle
consisted of adding ligation mixture to the beads containing
monomer and the relevant capping oligo and incubating at
room temperature for 2min, followed by two washes before
the nextligation. Inthisway,20consecutiveligationscanbe
performed in <90min. In the ﬁnal ligation step for each
TALE we added the relevant terminator oligonucleotide,
followed by a wash and then heat elution of all DNAs
from the beads. We performed PCR of the eluted DNA,
usingprimerscomplementarytotheinitiatorandterminator
oligos, with SYBR green I in a real-time PCR machine in
ordertomonitorampliﬁcationandstopitbeforetheplateau
phase. Thismonitoringisnecessarybecause of the repetitive
nature of TALE genes; we have observed that over-
ampliﬁcation of TALEs leads to ladder-like PCR products
indicating inter-amplicon recombination (also seen in
TALEN colony PCRs, see Figure 3). Gel electrophoresis
revealed the presence of clean bands of the expected size
for every TALE sample except the one (TAL19nb) in
which capping oligonucleotides were omitted in synthesis.
TAL19nb showed a full-length band and also stronger
bands of shorter sizes spaced at  300bp intervals. These
bands presumably correspond to TALE chains that were
incompletely ligated in one or more steps and became
re-extended in a later ABC cycle which would be multiples
of three ligation steps later (each monomer is 102bp). The
absence of truncated bands in the samples where capping
oligonucleotides were used indicates effective capping of in-
complete chains by these oligonucleotides. We then puriﬁed
all products and assembled them into a FokI-containing
backbone plasmid by Golden-Gate ligation (18). After
transformation into TOP10 cells, which generated dozens
of colonies per TALEN construct, we grew and puriﬁed
the plasmids of six colonies per TALEN and digested with
AfeI to reveal the length of the cloned TALE inserts. The
four TALENs where capping oligos were used generated
between 4/6 and 6/6 full-length clones whereas the
no-capping sample generated 0/6, again showing the
beneﬁt of the capping approach. We sequenced four
full-length clones per successful construct and found
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rate: TAL11, 1/4 clones; TAL15, 4/4; TAL18, 4/4 and
TAL19, 2/4. Observed errors were one stop codon, one
coding substitution and three one-base deletions, probably
stemmingfrommonomerPCRduetopolymerase orprimer
synthesis errors.
A reporter system to test TALEN pair
activity in human cells
To test the scalability of ICA and to investigate how
effectively TALENs synthesized with this approach can
be used in genome engineering, we constructed a human
cell reporter system with which we could measure the
activity of multiple TALEN variants. We generated a
monoclonal 293T cell line carrying two lentiviral inser-
tions of a defective EGFP gene driven by the EF1a
promoter (Figure 2a). In these cells, EGFP is transcribed
but not translated since it carries ACG at the expected
ATG start codon site. Gene editing by knock-in of a
75-nt single-stranded donor oligonucleotide carrying a
functional ATG start codon should in theory rescue
EGFP expression. Since genomic incorporation of hom-
ologous single-stranded donor DNA is greatly increased
by a DNA cut close to the desired incorporation site (26),
we expected that activity of our TALENs could be quickly
assayed by measuring EGFP expression frequency of cells
transfected with the donor and TALEN pairs designed to
ﬂank the target site. We designed 10 left variants and 11
right variants of TALENs of different length (11–21
monomers) that ﬂank the defective ACG start codon on
the EGFP gene. We left a constant 17bp gap between the
TALENs. In this design, the TALENs cover a range of
DNA bases at their C-terminus encoded ‘0th
’ position.
Bioinformatic and structural studies have suggested that
a thymine is necessary at this base for optimal activity
(10,12,15,25), but some contrary evidence exists
(13,17,27,28) and empirical testing of this question with
multiple custom TALENs has not been reported.
ICA of TALEN variants targeting the reporter gene
Weﬁrstperformedligationsforthe10rightTALEdomains.
PCR ampliﬁcation of the eluted ligation products generated
clean,full-lengthproductsforallTALENconstructs(Figure
2b). We cloned the products using the Golden-Gate method
intothenucleasevectorandsixcolonyPCRswereperformed
perTALEN(SupplementaryFigureS1).Between4/6and6/
6,coloniesshowedfull-lengthinsertsforeachTALEN.Two
such colonies were grown up per TALEN and sequenced,
revealing at least one perfect clone for all except one
TALEN. For R15, frameshift mutations or premature stop
codons were detected in 26/26 sequenced colonies, suggest-
ing that this TALEN sequence was toxic to Escherichia coli.
Ligation and synthesis were then performed for the 10 left
TALENs (Supplementary Figure S2). We synthesized
L14-L11 with exactly the same protocol as the right
TALENs, with similar results and cloning success rate. In
contrast,intheproductionofL20-L15wehalvedtheamount
of monomer (to 25ng) and ligase (to 0.25ml) in each step to
reducereagentcosts.Althoughperfectcloneswerefoundfor
L20-L15, aberrant PCR products in gels (Supplementary
Figure S2) and the need to screen many colonies (up to 24)
suggest that these reagent levels are too low for efﬁcient
assembly. L15 was later dropped as the selected
sequence-veriﬁed clone failed to grow when we prepared all
TALENs in parallel for the gene editing experiment.
Conﬁrming activity of TALENs and
HR in the reporter cells
Having designed and synthesized the TALEN variants, we
ﬁrst transfected the reporter cells carrying defective EGFP
with combinations of the L19/R19 TALEN pair and the
donor oligonucleotide (Figure 2c) and incubated for 96
hours. Encouragingly, transfection of the L19/R19 pair
plus the donor oligo led to 1.8% of cells expressing
EGFP, suggesting the occurrence of TALEN-mediated
gene editing. Transfection of the donor, L19 or R19 alone
gave negligible EGFP expression. Interestingly, transfec-
tion of the L19/R19 pair without donor resulted in a
small but measurable number of EGFP-positive cells
(0.1%). To conﬁrm occurrence of gene editing and/or
NHEJ, we PCR ampliﬁed, cloned and sequenced a
189-bp region around the TALEN target site in unsorted
and EGFP+sorted populations of TALEN-pair only and
TALEN pair-plus-oligo-treated cells (Figure 2d,
(a)( b)( c)( d)
Figure 3. Accelerating TALEN production by ICA. (a) PCR ampliﬁcation of repetitive DNA such as TALEs frequently generates artifacts, for
example in colony PCR of an assembled TALEN (lane (i)). We found that using PCR primers in the vector far away ( 1400bp) from the repetitive
TALE region dramatically reduces artifacts resulting in clean PCR products (ii) that can be directly sequenced saving a day’s wait for plasmid
preparation, or digested with AfeI (iii) to reveal the TALE insert length (red arrow). (b) We tested whether the PCR step after ICA ligation on beads
can be omitted by performing Golden-Gate assembly of two 19-monomer long (excluding the 0th position) TALEs into the nuclease vector directly
on the beads. (c) After transformation hundreds of colonies were generated, with the L19 and R19 constructs respectively generating 8/10 and 10/10
AfeI-digested colony PCRs with full-length inserts (red arrows). (d) A realistic three-day work schedule using the methods presented here from
TALEN design to transfection of target cells.
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pair only, 18/23 (78%) of clone sequences from unsorted
cells showed small deletions indicative of NHEJ, indicating
a remarkably high cutting activity of this TALEN pair.
Similarly, from the EGFP+ sorted cells from the same
treatment, 23/24 clones showed evidence of NHEJ. We
could not infer from the sequences why these cells had
become EGFP positive. However, rearrangements in one
reporter copy that put the EGFP coding sequence into an
open reading frame may have removed the PCR priming
sites, with the result that all observed sequences stem from
the second reporter copy. In unsorted cells treated with the
TALEN pair and donor, 19/21 sequences showed evidence
of NHEJ with no evidence of gene editing. However, in the
EGFP+sorted cells from the same treatment, 6/17 clone
sequences (Figure 2d) matched the donor sequence,
indicating successful editing, while 10/17 sequences
showed NHEJ. Since there are two genomic insertions in
the reporter cells, it isexpected thatPCR products from the
sorted cells will contain a mixture of products, with half
showing the gene editing events leading to EGFP expres-
sion and the rest showing the second genomic reporter
copy, which in this assay mostly shows NHEJ events. We
conclude that TALENs can stimulate gene editing by an
oligonucleotide donor and therefore that measuring
EGFP expression frequency after transfection allows
rapid assessment of TALEN activity on our reporter
system.
Testing the TALEN length variants and different 0th
position bases
HavingdemonstratedactivityofTALENsandgeneediting
on our reporter system, we then transfected the reporter
cells with combinations of our left and right TALEN
variants, each time including the EGFP-correcting donor
to allow rapid ﬂow cytometry measurement of TALEN
activity. Since we had shown that L19 and R19 are func-
tional, we tested all of the right TALENs in combination
with L19 and all the left TALENs with R19. All conditions
were tested in triplicate. Interestingly, ﬂow cytometry
(Figure 2e) revealed that all TALEN pairs tested generated
EGFP-positive cells after 96h and thus possess cutting
activity. For the right TALENs tested together with L19,
performancewassimilaramongallexceptthethreeshortest
TALENs. These three TALENs show a pattern of
decreasing activity with decreasing length such that R12
generated  6-fold fewer EGFP+cells than R15 and those
longer. For the left TALENs tested with R19, a similar
pattern was observed except for one exception: L12
showed high activity, whereas L14, L13 and L11 showed
reduced activity. Interestingly, most TALENS showed
similar results despite overlapping different DNA bases at
their C-terminus-encoded 0th position. Although the 0th
position of at least one TALEN (L19 or R19) overlapped
a T in all pairs tested, average EGFP+frequencies were not
obviously affected by the 0th position base of the second
TALEN:T:1.4%(n=4);C:1.7%(n=7);A:1.5%(n=4)
and G: 0.8% (n=3). We conclude that a 0th position
thymine is not strictly necessary for TALEN activity
although there are several possible explanations for this
ﬁnding (see ‘Discussion’ section).
Further accelerating ICA
We next sought to further increase the speed and efﬁciency
of ICA. First, wenoted that while assembly of a TALEN by
ICA takes a single day, 3 days are needed subsequently for
colony PCR, overnight clone culture, plasmid puriﬁcation
and sequencing before a sequence-veriﬁed construct can be
transfected into target cells. Sequencing the TALEN colony
PCR product rather than a puriﬁed plasmid would save a
day and considerable work; however, colony PCR of repeti-
tive DNA such as TALENS tends to generate ladder-like
bands, presumably from inter-template recombination
(Figure 3a(i)), that prohibit effective sequencing. We
reasoned that a much longer colony PCR amplicon would
suffer less from this problem, since the TALE sequence will
form a much smaller fraction of the amplicon and be
situated further from the amplicon ends. We indeed found
that a colony PCR amplifying the entire TALEN gene
produces much cleaner products (Figure 3a(ii)), with brief
AfeI digestion of the raw PCR product allowing easy gel
visualization of the TALEN insert size (Figure 3a(iii). We
ampliﬁed and sequenced long amplicons from two previ-
ously veriﬁed L19 colonies and found that the products
indeed generate high-quality correct sequences. We next
noted that the post-elution PCR step in ICA takes some
time and introduces some risk of PCR artifacts. Therefore,
we investigated whether this step could be eliminated by
direct assembly of the ligation products from the beads
into the backbone vector (Figure 3b). We resynthesized
TALENs L19 and R19 from monomers under the same
conditions as before, except this time after the ﬁnal
ligation step, whereas the TALE chains were still attached
to the beads, the beads were washed once in TE and resus-
pendedintheGolden-Gateassemblymixwiththebackbone
plasmid. The beads–assembly mixture was subjected to the
same Golden-Gate thermal cycling conditions as before and
transformeddirectlyintoTOP10cells.Hundredsofcolonies
were generated from each construct, with 8/10 and 10/10
colony PCRs showing full-length inserts for L19 and R19,
respectively. Five full-length clones were sequenced per
construct, with 4/5 and 3/5 showing perfect sequence.
These results compare very favorably with the results
generated from the PCR-then-assembly protocol (Table 1).
Therefore, the PCR step after TALE ligation can indeed be
bypassed,substantiallysimplifyingTALENconstructionby
ICA. Taken together, our elimination of the PCR step and
theexpeditedcolonyPCRandsequencingapproachreduces
the time between TALE design and transfection into target
cells to 3 days, the shortest such time so far reported.
DISCUSSION
A desirable way to synthesize long repetitive DNA, which
is refractory to current high-throughput DNA synthesis
methods (6,7), would be to sequentially couple DNA
repeat modules by ligation on a solid surface, in a
process analogous to chemical oligonucleotide synthesis
from single nucleotides (5). However, in contrast to
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with coupling efﬁciencies >99.5% (5), enzymatic ligation
of relatively large DNA monomers may not be similarly
efﬁcient. This is critical since a drop in coupling efﬁciency
just to 90% would result in only  12% full-length chains
after 20 consecutive ligations. In addition, although
nucleotides can be chemically protected and deprotected
to prevent self-coupling during single attachment steps (4),
analogous processes are not trivial for oligonucleotide
ligation, likely requiring further enzymatic steps with
sub-optimal efﬁciencies. Our ICA method overcomes
these problems by alternating between three versions
(A–C) of each monomer in the ligation steps, which as
well as preventing monomer self-ligation permits inclusion
in each step of a ‘capping’ oligonucleotide that can ligate
to incompletely extended chains from the previous step.
The capping oligonucleotides are hairpin-based short
single strands, which makes them stoichiometrically
perfect, rapidly diffusible and cheap to use in high molar
concentrations, leading to high capping efﬁciency.
Here wehavetested ICAoncustom TALEgenes. Dueto
their highly repetitive nature, custom TALEs have mostly
been synthesized by multi-step hierarchical ligation and
cloning. Most recent methods (15,18,20,24) use variations
ofGolden-Gatecloning(22),inwhichaTypeIISrestriction
enzyme allows the creation of position-speciﬁc overhangs
on monomers (prepared from PCR or plasmids) for
multi-piece, deﬁned-sequence ligation in a single reaction.
While effective, these methods required extensive initial
formatting of the monomers or pre-fabricated dimers into
many different position-speciﬁc forms whether through
PCR (18,24) or construction of large (>70) plasmid
libraries (15,20). Due to limits in the number of pieces
Golden-Gate ligation can assemble in one reaction, the
studies cited above required multiple rounds of assembly
and hence between 2 and 5 days to produce new TALEs
with target sites >14bp. Recently, Reyon et al. presented
FLASH (19), the ﬁrst automated method of TALE synthe-
sis which like ICA builds TALEs by sequential ligation on
magnetic beads. FLASH is a powerful method that can
produce dozens of TALENs per day in parallel using an
automated liquid handing station. However, FLASH
builds TALEs from oligomers (mostly 4-mers) rather
than monomers, picked from an exhaustive pre-fabricated
libraryof376plasmids.Thisreducesthenumberofligation
reactionsneededtomakefull-lengthTALEs,whichislikely
necessary given that capping oligonucleotides are not used
in FLASH (although in theory they could be introduced to
this method to improve efﬁciency). However, reliance on
the oligomer library will make it cumbersome to replace
individual monomers with new ones of improved design
and combinatorially virtually impossible to expand the
routine repertoire of monomers much beyond 4. We
envisage multiple reasons to add new TALE monomers
to the standard repertoire, such as incorporation of
monomers tagged with ﬂuorescent or activatable moieties
or ones that target epigenetically modiﬁed bases, or even
thecreationofhybridDNA-bindingdomainsthatcombine
TALEswithothermotifssuchaszincﬁngers.ICAis,toour
knowledge, unique in providing an automatable platform
that can produce full-length TALEs from individual
monomers, with only three or four PCRs needed to intro-
duce any new module to the repertoire. In addition, since
each ligation step picks from only four standard monomers
rather than hundreds of oligomers and takes place rapidly
(2min) at room temperature, ICA is likely to be applicable
to current to microarray printing technology to allow pro-
duction of libraries of thousands of TALE constructs. We
note that for effective production of large TALE libraries,
the error rate of individual constructs (Table 1) must be
reduced. However, since most errors we observed likely
stem from primer or polymerase errors introduced during
monomer PCR, the majority of these might be removed by
preparing monomers in future from digested plasmids (15)
rather than PCR.
In testing the TALENs we produced by ICA, we used
an oligonucleotide donor to genomically modify a
reporter gene after a TALEN-stimulated chromosomal
break, representing to our knowledge the ﬁrst report of
TALEN-oligonucleotide gene editing. Sequence analysis
showed that the L19/R19 TALEN pair very efﬁciently
cut the target site, with up to 80% of alleles showing
evidence of NHEJ 4 days after TALEN transfection.
However, the frequency of donor oligonucleotide incorp-
oration was considerably lower, with only 1–2% of cells
becoming EGFP positive. Since oligonucleotides carry
advantages over longer donor DNA in terms of cost and
design simplicity, future work into increasing the ratio of
gene editing to NHEJ after TALEN cutting would be ex-
tremely useful. By testing our TALEN length variants in
human cells, we found that all TALENs tested showed
activity, although TALENs shorter than  15 monomers
long tended to be less effective than longer ones, support-
ing the need for a synthesis method that can produce
Table 1. Summary of cloning and sequencing success using two variants of the ICA protocol
Full-length clones
a Perfect sequence clones
ICA protocol variant No. constructs made Worst construct Best construct Worst construct Best construct
PCR then assembly 18
b 4/6 6/6 1/4
c 4/4
Direct assembly off beads 2 8/10 10/10 3/5 4/5
The table shows the range of success rates (full-length clone frequency after TALEN assembly and perfect sequence frequency among selected
full-length clones) observed among all constructs built with two variants of the ICA method.
aAlthough dozens to hundreds of colonies were generated per construct, only 6–10 colonies were analyzed.
bThese 18 constructs include the four constructs made with capping oligos in Figure 1 and L14-L11 and R21-R11 from Figure 2. L20-L15 are not
included as they were synthesized with reduced amounts of monomer and ligase, which turned out to be detrimental.
cR15 is not included as it produced zero perfect sequences from 26 full-length clones and is therefore likely to be toxic to E. coli.
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assay, we observed similar target repair activity among
several TALENs with different bases at the 0th position,
indicating that a thymine at this position is not strictly
required for TALEN activity. This result, which contrasts
with previous bioinformatic, crystal structure and some
empirical data (10,12,15,25) but agrees with others
(13,17,27,28), may have several explanations. TALENs
as long as the ones we used may be tolerant of the
decrease in binding afﬁnity at any single site including
the 0th position. We also note that using EGFP rescue
of our reporter system as a measurement of TALEN
activity may become less accurate once TALEN cutting
efﬁciency approaches 100%, since donor DNA incorpor-
ation will become the limiting factor in the rescue rather
than target site cutting. In addition, since at least one of
each TALEN pair tested did overlap a 0th position
thymine, FOKI recruitment effects might be acting to
increase activity of the other TALEN. Nevertheless, our
results generally support and extend recent ﬁndings (19)
that TALENs can be conﬁdently adapted for new targets
with minimal design constraints, supporting the usefulness
of high-throughput synthesis of TALENs and other
TALE-fusion genes. In summary, ICA is a fast, efﬁcient
and scalable method of producing repetitive modular
DNA of deﬁned sequence. Although here we have
applied the method to TALE-gene synthesis, we believe
the approach should be useful for production of other
modular constructs in synthetic biology (29) where there
is increasing demand for rapid DNA assembly-from-parts.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1 and 2, Supplementary Figures
1–3 and Supplementary plasmid maps.
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